Disclosures for "The Source and Pathogenic Potential of Blood-derived Alpha-Synuclein"
-
Dr. Kannarkat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global.
-
Ms. Lewis has nothing to disclose.
-
Author has nothing to disclose
-
Mr. Unger has nothing to disclose.
-
Rebecca Zack has nothing to disclose.
-
Dr. Tropea has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. The institution of Dr. Tropea has received research support from NINDS. The institution of Dr. Tropea has received research support from Parkinson Foundation. The institution of Dr. Tropea has received research support from Michael J Fox Foundation.
-
Author has nothing to disclose
-
The institution of Kelvin Luk has received research support from National Institutes of Health. The institution of Kelvin Luk has received research support from Michael J. Fox Foundation. The institution of Kelvin Luk has received research support from Teva Pharmaceuticals.
-
Dr. Ter-Ovanesyan has received intellectual property interests from a discovery or technology relating to health care.
-
Virginia Lee, PhD has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Chen-Plotkin has received intellectual property interests from a discovery or technology relating to health care.